2:15pm - 2:45pm Monday, March 9

Location & Room

Orlando - Hyatt Regency
Hyatt - Orlando Ballroom M
Extra Fee

Why have digital therapeutics not yet joined the healthcare mainstream? Why are more physicians not prescribing them and more patients not using them? And why are pharmaceutical companies not investing more in R&D for digital therapeutics, preferring to test the water with relatively small investments in partnerships and acquisitions?

This session will address these questions head on and look at forces that might drive greater acceptance in the future.

Senior Director, Head of Products, Digital Health,
Teva Pharmaceuticals
Sr. Director Customer Experience Strategy and Portfolio Management,
Florida Blue
Executive Director,
Digital Therapeutics Alliance
Chief Executive Officer,
Health Innovation Strategies
Senior Director, Digital Medicine,
Otsuka Pharma